Fundraise (min £4.7 million 💪) Will it be confirmed tomorrow27 Apr 2025 14:53
SOLVONIS THERAPEUTICS PLC
(Incorporated and registered in England and Wales with registered
number 10776788)
Proposed acquisition of Awakn Life Sciences Corp.,
proposed authority to issue up to 7,500,000,000 new Ordinary Shares
a) £2,777,844.024 (being equal to 2,777,844,024 ordinary shares of £0.001 in the capital of the Company
(“Ordinary Shares”)) in connection with the Proposed Acquisition (as defined in the document of which
this notice of general meeting (“Notice”) forms part); and
(b) £4,722,155.97 (in addition to the authorities conferred in sub-paragraph (a) above) being equal to
4,722,155,976 Ordinary Shares, provided that (unless previously renewed, revoked, varied or extended
by the Company at a general meeting), these authorities shall expire at the end of the next annual general
meeting of the Company to be held after the date of the passing of this resolution, save that the Company
may at any time before such expiry make an offer or agreement which would or might require relevant
securities to be allotted after such expiry and the directors may allot relevant securities under such an
offer or agreement as if the authority granted by this resolution had not expired.
a) £2,777,844.024 (being equal to 2,777,844,024 ordinary shares of £0.001 in the capital of the Company
(“Ordinary Shares”)) in connection with the Proposed Acquisition (as defined in the document of which
this notice of general meeting (“Notice”) forms part); and
(b) £4,722,155.97 (in addition to the authorities conferred in sub-paragraph (a) above) being equal to
4,722,155,976 Ordinary Shares, provided that (unless previously renewed, revoked, varied or extended
by the Company at a general meeting), these authorities shall expire at the end of the next annual general
meeting of the Company to be held after the date of the passing of this resolution, save that the Company
may at any time before such expiry make an offer or agreement which would or might require relevant
securities to be allotted after such expiry and the directors may allot relevant securities under such an
offer or agreement as if the authority granted by this resolution had not expired.
Sign In
Follow the stocks
